Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining α-blockers with 5α-reductase inhibitors improves symptoms and outcomes for severe benign prostatic hyperplasia.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Minoxidil can cause pericardial and pleural effusions with high protein content.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

5-Alpha-Reductase Inhibitors can cause negative side effects.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Tadalafil is effective for treating urinary symptoms in men with BPH.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Minoxidil promotes hair growth by increasing blood flow and directly affecting hair follicles.

Deoxycorticosterone and its metabolites help prevent seizures by interacting with specific receptors.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Botulinum toxin-A may increase hair growth and reduce hair loss in men with baldness, and injecting near blood vessels can improve pain relief and last longer.

GD-23 reduces anxiety by relying on neurosteroid production.

Magnesium deficiency raises diastolic blood pressure and reduces vascular contraction.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Potassium channel activators like nicotinamide and minoxidil might help treat solid tumors.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Minoxidil protects heart and improves recovery.

Adiantum capillus extract reduces pain and swelling in animals.

Finasteride may help treat BPH by affecting certain biological markers.

Clove, cinnamon, and coriander extracts may help reduce blood vessel growth.

A new compound may treat benign prostatic hyperplasia better than finasteride.